Home › Novartis Launches Strenzen for Treatment of Respiratory, Enteric Diseases in Pigs
 

Keywords :   


Novartis Launches Strenzen for Treatment of Respiratory, Enteric Diseases in Pigs

2014-04-14 02:00:00| ThePigSite - Industry News

SWITZERLAND - Novartis Animal Health (NAH) announced today the launch of Strenzen® (amoxicillin, clavulanic acid), an oral water medication for pigs containing a combination of amoxicillin trihydrate (500 mg/g) and potassium clavulanate (125 mg/g) in ratio of 4:1.

Tags: treatment diseases respiratory launches

Category:Agriculture and Forestry

Latest from this category

All news
15.05Exploring the future of agriculture
15.05American, Mexican, and Canadian cattle producers sign joint statement
15.05AgSpire partners with South Dakota State University & others to advance resilience on cattle ranches
15.05TSCRA Disaster Relief Fund distributes $900,000 in financial assistance
15.05Cost of bulls in a stocker program during receiving period explored
15.05Marbling is a beef industry success story
15.05Pork has its place in healthy, sustainable global diets
15.05Iowa food pantries benefit from Pork in the Pantry donations
Agriculture and Forestry »
16.05Eastern North Pacific Tropical Weather Outlook
16.05Atlantic Tropical Weather Outlook
16.05China's Nio unveils Tesla Model Y rival
16.05Could the US economy be doing too well?
16.05Eastern North Pacific Tropical Weather Outlook
16.05Atlantic Tropical Weather Outlook
16.05The man who turned his dead father into a chatbot
16.05Firms leaving UK 'not a crisis' says stock market boss
More »